1. Introduction
===============

Polychlorinated biphenyls (PCBs), which belong to a class of chemicals called chlorinated hydrocarbons, are well-known environmental pollutants that have been widely used industrially and commercially for more than half a century \[[@b1-ijms-13-15955],[@b2-ijms-13-15955]\]. PCB contamination is a serious environmental problem in China. For example, the total concentration of PCBs in some surface water and surface microlayers exceeds the limits set by the "Environmental Quality Standard for Surface Water" in the Jiangsu Province \[[@b3-ijms-13-15955]\]. Numerous reports and studies have confirmed that PCB exposure leads to an increase in the incidence and severity of cardiovascular disease \[[@b4-ijms-13-15955],[@b5-ijms-13-15955]\], but little is known about the underlying molecular mechanisms.

MicroRNAs (miRNAs) are an abundant class of small non-protein-coding RNAs that have been shown to play critical roles in a wide range of biological and pathological processes, including cardiac development and congenital heart defects \[[@b6-ijms-13-15955]\]. However, the role of miRNAs in the differentiation of cardiomyocytes that have been exposed to PCBs has not been investigated thus far. The P19 mouse embryonal carcinoma cell line is a suitable model for studying cardiac differentiation at the molecular and functional levels. In the present study, we initially investigated the differential expression profiles of miRNAs during the differentiation of P19 cells exposed to Aroclor 1254. We used Aroclor 1254 because it is a well-known hepatotoxin and consists of a complex mixture of PCBs \[[@b7-ijms-13-15955]\]. We subsequently confirmed the microarray results by real-time reverse transcription polymerase chain reaction (real-time RT-PCR). Furthermore, we investigated changes in the expression of the target genes of some miRNAs.

2. Results and Discussion
=========================

2.1. Assessment of Cell Differentiation
---------------------------------------

To investigate the differentiation of P19 cells into mature cardiomyocytes, we used Western blotting to identify the expression of cTnT protein (a myocyte differentiation marker). [Figure 1](#f1-ijms-13-15955){ref-type="fig"} shows the increase in cTnT expression, indicating the differentiation of the cells into cardiac myocytes.

2.2. Morphology of P19 Cells during Differentiation
---------------------------------------------------

The changes in the morphology of P19 cells during differentiation were examined and photographed with an inverted microscope. P19 cells were allowed to aggregate from day 0 to day 4, and beating colonies were found on day 10. No significant differences in morphology were observed between P19 cells that had been exposed to PCBs and the control cells ([Figure 2](#f2-ijms-13-15955){ref-type="fig"}).

2.3. miRNA Expression Profiles in P19 Cells Exposed to PCBs Relative to Control Cells
-------------------------------------------------------------------------------------

miRNA microarrays are a powerful tool for studying the biological function of miRNAs. Every sample was repeated three times to improve miRNA microarray accuracy ([Figure 3](#f3-ijms-13-15955){ref-type="fig"}). The miRNA expression pattern was found to be significantly different between cells that had been exposed to PCBs and controls ([Table 1](#t1-ijms-13-15955){ref-type="table"}). A total of 45 miRNAs were differentially expressed in cardiomyocytes that differentiated from P19 cells exposed to PCBs (day 10) compared with normal cells (day 10). Specifically, 14 miRNAs were found to be upregulated and 31 miRNAs were downregulated in P19 cells exposed to PCBs.

2.4. Validation of Differentially Expressed miRNAs
--------------------------------------------------

Eight miRNAs (miR-126-5p, miR-99a, miR-324-5p, miR-762, miR-29a, miR-302c, miR-295, miR-20b) were randomly selected to confirm the microarray results using real-time RT-PCR. The expression data obtained by real-time RT-PCR analysis were comparable to the results of the miRNA microarray analysis ([Figure 4](#f4-ijms-13-15955){ref-type="fig"}).

2.5. miRNA Target Predictions
-----------------------------

In the course of exploring the targets of these miRNAs by computational prediction, we found that *Wnt1*, *GSK3*β, and *NKX2.5* were potential targets of miR-762, miR-29a, and miR-324-5p, respectively. The results of real-time RT-PCR analysis showed that the expression of *Wnt1* and *NKX2.5* was downregulated in P19 cells that were treated with PCBs, whereas the expression of *GSK3*β was upregulated ([Figure 5](#f5-ijms-13-15955){ref-type="fig"}).

2.6. Discussion
---------------

The heart is the first organ formed in the developing embryo. Exposure to PCBs, some of the most ubiquitous environmental contaminants, is a risk factor for the development of cardiovascular diseases. In this study, we simulated the exposure of PCBs with Aroclor 1254 at a concentration of 2.5 μmol/L, which is the concentration used in most experiments that examine the effect of PCBs on cells \[[@b2-ijms-13-15955]\]. The P19 mouse embryonal carcinoma cell line can be specifically induced to differentiate into cardiac muscle cells, and is therefore one of the most suitable models for studying cardiac differentiation at the molecular and functional levels \[[@b8-ijms-13-15955]\]. Thus, we selected the P19 cell line to investigate the differential expression profiles of miRNAs in the differentiation of P19 cells exposed to PCBs into cardiomyocytes.

In our initial expression profiling experiment we identified 45 miRNAs that were differentially expressed between P19 cells treated with PCBs and control cells. In particular, 14 miRNAs were upregulated and 31 were downregulated in P19 cells that had been exposed to PCBs during the differentiation process. To validate the microarray results, eight miRNAs were selected for further experimental confirmation: miR-126-5p, miR-99a, miR-324-5p, miR-762, miR-29a, miR-302c, miR-295, miR-20b. The expression levels of these miRNAs were measured with real-time RT-PCR, and the changes in the expression of all eight miRNAs were found to be consistent with the microarray data.

The role of miRNAs in cardiac development and cardiovascular disease has begun to be uncovered. MiR-208a has been previously shown to be necessary for normal cardiac conduction. The expression level of miR-208a has been demonstrated to gradually increase during mouse heart development. Transgenic overexpression of miR-208a was sufficient to induce hypertrophic growth in the mouse heart \[[@b9-ijms-13-15955]\]. In the present study, miR-208a was upregulated in P19 cells exposed to PCBs, and could therefore have a role in the development of heart disease caused by PCB exposure. The results of a previous study suggest that miR-21 can protect against H~2~O~2~-induced injury via the induction of its target gene in cardiac myocytes \[[@b10-ijms-13-15955]\]. Dong *et al.* also demonstrated the protective effect of miR-21 against ischemia-induced cardiac myocyte damage, an effect mediated by decreased cell apoptosis \[[@b11-ijms-13-15955]\]. In our study, miR-21 was downregulated during differentiation in P19 cells exposed to PCBs. We speculate that PCBs might cause heart disease by downregulating the expression of miR-21. In the present study, the expression of *NKX2.5* was reduced in P19 cells treated with PCBs and *NKX2.5* is a potential target of miR-324-5p. *NKX2.5*, a member of the NK2 class homeodomain protein, is one of the earliest genes expressed in vertebrate heart development. *Nkx2.5* plays an important role in the development of heart tube, ventricular septal and endocardial cushion \[[@b12-ijms-13-15955],[@b13-ijms-13-15955]\]. This suggests that miR-324-5p might be important in controlling pathological events in congenital heart disease caused by exposure to PCBs.

Numerous reports and studies show that the Wnt signaling pathway has a key role in the process of cardiovascular differentiation and morphogenesis \[[@b14-ijms-13-15955],[@b15-ijms-13-15955]\]. At the cell surface, Wnt proteins activate the pathway through binding a receptor complex containing Frizzled, whereas GSK3β negatively regulates the pathway \[[@b16-ijms-13-15955]\]. During the differentiation of P19 cells treated with PCBs, we found that increased expression of miR-762 was associated with a decrease in the expression of *Wnt1* and an increase in *GSK3*β expression. These findings indicate that miRNAs usually cause translational repression or target degradation and gene silencing \[[@b17-ijms-13-15955]\]. The function of these miRNAs, and the relationship between miRNAs and their targets, requires further confirmation and study.

3. Experimental Methods
=======================

3.1. Cell Culture
-----------------

The P19 mouse embryonal carcinoma cells used in this study were obtained from the American Type Culture Collection (ATCC, Manassas, VA, USA). In order to induce cardiac differentiation, the cells were cultured in α-MEM (Gibco BRL, Grand Island, NY, USA) containing 10% fetal bovine serum (FBS; Gibco BRL), 100 U/mL penicillin, and 100 μg/mL streptomycin at 37 °C in 5% CO~2~ until confluence. After 48 h, at which point the cells had reached confluence (day 0), the cells were cultured in α-MEM, 1% DMSO (Sigma, St. Louis, MO, USA), 10% FBS, 100 U/mL penicillin, and 100 μg/mL streptomycin for 96 h (day 4) in bacteriological dishes. The cell aggregates were transferred to 6 cm bacterial dishes, and cultured in α-MEM containing 10% FBS for an additional 4 or 6 days (day 10) until the cells differentiated into beating cardiomyocytes. The morphological changes of the cells were examined and photographed with an inverted microscope (Nikon, Japan).

Solutions of Aroclor 1254 at a concentration of 2.5 μmol/L were prepared in DMSO. The Aroclor 1254 was added into the medium on day 0 of differentiation. We chose this concentration because it has been used in a previous study \[[@b2-ijms-13-15955]\]. The same amount of DMSO diluted with the culture medium was used as a control.

3.2. Western Blotting
---------------------

Treated cells were washed with ice-cold PBS and lysis buffer (50 mmol/L Tris-HCl, 1% Triton X-100, 0.2% sodium deoxycholate, 0.2% SDS, and 1 mmol/L EDTA at pH 7.4) and vortexed briefly. The lysate supernatant was collected after centrifugation at 15,200× *g* at 4 °C for 15 min. Protein levels were quantified using a protein assay reagent kit, and quantification was performed as described previously \[[@b18-ijms-13-15955]\]. Western blotting was carried out using a monoclonal rabbit anti-cTnT antibody (Chemicon, Temecula, CA, USA) and a monoclonal rabbit anti-GAPDH antibody (Proteintech Group, Inc., Wuhan, China).

3.3. Total RNA Preparation
--------------------------

Total RNA was extracted from cardiac myocytes (on day 10) that had been exposed to either Aroclor 1254 or the control solution. Total RNA was extracted by using Trizol (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions. Total RNA was quantified by a nanodrop spectrophotometer (ND-1000; NanoDrop Technologies, Wilmington, DE, USA).

3.4. MiRNA Microarray
---------------------

Microarrays were performed by utilizing the miRCURY LNA™ microRNA Array (Version 14.0 Exiqon, Vedbaek, Denmark). All procedures were carried out according to the manufacturer's instructions. After having passed RNA measurement on the NanoDrop instrument, the samples were labeled using the miRCURY™ Hy5™/Hy3™ Power labeling kit (Exiqon) and hybridized on the miRCURY LNA™ Array (v.14.0), which contains more than 1700 capture probes covering all miRNAs listed in miRBase version 14.0. After stopping the labeling procedure, the Hy3™-labeled samples and a Hy5™-labeled reference RNA sample were mixed pairwise and hybridized to the miRCURY LNA™ Array version 14.0 (Exiqon). The hybridization and subsequent wash steps were performed according to the miRCURY LNA™ array manual. The microarray slides were scanned using the ScanArray™ 4000 XL scanner (Packard Biochip Technologies, Billerica, MA, USA) and the image analysis was carried out using the ImaGeneTM 6.1.0 software (BioDiscovery, Inc., El Segundo, CA, USA). The normalized data was analyzed using the locally weighted scatter plot smoothing (lowess) regression algorithm (MIDAS, TIGR Microarray Data Analysis System). Statistical comparisons were performed by using the analysis of variance (ANOVA) statistic.

3.5. Validation of Microarray Experiments
-----------------------------------------

Real-time RT-PCR analysis was performed to validate the miRNA microarray results. Total RNA was isolated from cultured cells with Trizol (Invitrogen, Carlsbad, CA, USA). The reverse transcription mixture contained 1 μg total RNA, 0.5 μL miRNA reverse primer (1 μM) ([Table 2](#t2-ijms-13-15955){ref-type="table"}), 0.3 μL RNase inhibitor (40 U/μL), 2 μL 10× buffer, 2 μL RNasin (10 U/μL), and an appropriate amount of RNAse-free H~2~O to a total volume of 20 μL. The reverse transcription reaction was performed at 16 °C for 30 min, then 42 °C for 40 min, followed by heat inactivation at 85 °C for 5 min. Real-time PCR analysis was performed on an ABI 7300 real-time PCR system (Applied Biosystems, Carlsbad, CA, USA) with a 25 μL volume reaction containing 2.5 μL reverse transcription product, 0.5 μL forward and reverse primer ([Table 3](#t3-ijms-13-15955){ref-type="table"}), and 12.5 μL SYBR-Green real-time PCR master mix. The reactions were incubated in 96-well plates at 95 °C for 5min, followed by 40 cycles (95 °C for 10 s, 60 °C for 20 s, 72 °C for 20 s, 78 °C for 20 s), and then ramped from 72 °C to 99 °C to obtain the melting curve. The *U6* expression level was used as an internal control for miRNA expression levels. All reactions were run at least in triplicate.

3.6. MiRNA Target Predictions and Real-Time RT-PCR
--------------------------------------------------

Predicted targets of miR-762, miR-29a, and miR-324-5p were analyzed in the Sanger Center miRNA registry \[[@b19-ijms-13-15955]\], TargetScan and PicTar target predictions \[[@b20-ijms-13-15955]\]. The expression of the target genes was measured using real-time RT-PCR. Briefly, RNA extraction, purification, and reverse transcription were performed as stated above. Real-time RT-PCR using the universal TaqMan probe was performed and the results were analyzed using a 7300 Real-Time PCR system under the following conditions: samples were incubated at 95 °C for 10 min for initial denaturation, followed by 40 cycles of amplification that were performed at 95 °C for 15 s and at 60 °C for 1 min. A modification of the 2^ΔΔ^*^C^*^t^ method was used to analyze the relative quantification data \[[@b21-ijms-13-15955]\]. *GAPDH* was used as the internal control gene. The sequences of the primers used are shown in [Table 4](#t4-ijms-13-15955){ref-type="table"}.

4. Conclusion
=============

In summary, we identified miRNAs that are differentially expressed during the differentiation of cardiomyocytes from P19 cells exposed to PCBs and control cells. Our results suggest that specific miRNAs could be directly involved in the development of cardiovascular disease resulting from exposure to PCBs. The function of these miRNAs will be analyzed in depth in the future.
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![Assessment of cell differentiation. Expression of cTnT protein as shown by Western blotting. Abbreviations: D0, day 0; D10, day 10.](ijms-13-15955f1){#f1-ijms-13-15955}

![Morphology of P19 cells during differentiation into cardiac myocytes (day 0, 4, 10). No significant difference in morphology was observed between P19 cells exposed to PCBs and the control cells. Abbreviation: PCBs, polychlorinated biphenyls.](ijms-13-15955f2){#f2-ijms-13-15955}

![Detection of miRNAs by miRCURY LNA™ microarrays. The microarray slides contained three replicate subarrays, Abbreviation: miRNA, microRNA.](ijms-13-15955f3){#f3-ijms-13-15955}

![Validation of microarray data using real-time RT-PCR. The real-time RT-PCR reactions were repeated three times for every miRNA. Error bars indicate standard error. \* *p* \< 0.05. Abbreviations: miRNA, microRNA; PCBs, polychlorinated biphenyls; RT-PCR, reverse transcription polymerase chain reaction.](ijms-13-15955f4){#f4-ijms-13-15955}

###### 

Expression of the miRNA targets as determined by real-time RT-PCR during the stimulation of differentiation (days 0 and 10). (**A**, **B**) The expression of *Wnt1* and *NKX2.5* was downregulated in P19 cells that were treated with PCBs, (**C**) whereas the expression of *GSK3*β was upregulated. \* *p \<* 0.05. Abbreviations: miRNA, microRNA; PCBs, polychlorinated biphenyls; RT-PCR, reverse transcription polymerase chain reaction.
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###### 

miRNAs differentially expressed between cardiomyocytes that differentiated from P19 cells exposed to PCBs (day 10) compared with normal cells (day 10).

  miRNA              Regulation   Log2   *p*-Value
  ------------------ ------------ ------ -----------
  mmu-miR-99a        Up           1.74   0.0060
  mmu-miR-214^\*^    Up           1.51   0.0365
  mmu-miR-345-5p     Up           1.57   0.0128
  mmu-miR-126-5p     Up           2.89   0.0338
  mmu-miR-762        Up           2.20   0.0242
  mmu-miR-324-5p     Up           1.90   0.0071
  mmu-miR-181a       Up           1.76   0.0318
  mmu-miR-302b^\*^   Up           2.83   0.0404
  mmu-miR-155        Up           1.97   0.0333
  mmu-miR-33         Up           1.90   0.0487
  mmu-miR-208a       Up           2.13   0.0465
  mmu-miR-10a        Up           1.84   0.0226
  mmu-miR-154        Up           1.64   0.0392
  mmu-miR-500        Up           1.53   0.0079
  mmu-miR-29a        Down         0.60   0.0139
  mmu-miR-302c       Down         0.65   0.0093
  mmu-miR-302b       Down         0.73   0.0249
  mmu-miR-293        Down         0.45   0.0349
  mmu-miR-294        Down         0.52   0.0284
  mmu-miR-295        Down         0.56   0.0410
  mmu-miR-7a         Down         0.62   0.0435
  mmu-miR-302a^\*^   Down         0.67   0.0203
  mmu-miR-1949       Down         0.58   0.0337
  mmu-miR-21         Down         0.63   0.0039
  mmu-miR-494        Down         0.54   0.0165
  mmu-miR-20b        Down         0.55   0.0349
  mmu-miR-200b       Down         0.14   0.0021
  mmu-miR-136        Down         0.37   0.0346
  mmu-miR-141        Down         0.05   0.0249
  mmu-miR-194        Down         0.02   0.0147
  mmu-miR-29b        Down         0.17   0.0350
  mmu-miR-32         Down         0.48   0.0075
  mmu-miR-710        Down         0.29   0.0120
  mmu-miR-290-3p     Down         0.35   0.0204
  mmu-miR-2133       Down         0.45   0.0072
  mmu-miR-18b        Down         0.61   0.0213
  mmu-miR-101a       Down         0.65   0.0273
  mmu-miR-326        Down         0.47   0.0095
  mmu-miR-669c       Down         0.35   0.0428
  mmu-miR-302d       Down         0.58   0.0113
  mmu-miR-2141       Down         0.25   0.0286
  mmu-miR-183        Down         0.60   0.0151
  mmu-miR-363        Down         0.56   0.0174
  mmu-miR-706        Down         0.64   0.0216
  mmu-miR-290-3p     Down         0.34   0.0439

###### 

Real time (RT) primer sequences.

  Gene name                          RT primer
  ---------------------------------- --------------------------------
  mmu-miR-126-5p                     5′ GTCGTATCCAGTGCGTGTCGTGGAGTC
  GGCAATTGCACTGGATACGACCGCGTA 3′     
  mmu-miR-99a                        5′ GTCGTATCCAGTGCGTGTCGTGGAGTC
  GGCAATTGCACTGGATACGACCACAAG 3′     
  mmu-miR-324-5p                     5′ GTCGTATCCAGTGCGTGTCGTGGAGTC
  GGCAATTGCACTGGATACGACACACCA 3′     
  mmu-miR-762                        5′ GTCGTATCCAGTGCGTGTCGTGGAGTC
  GGCAATTGCACTGGATACGACGCTCTG 3′     
  mmu-miR-29a                        5′ GTCGTATCCAGTGCGTGTCGTGGAGTC
  GGCAATTGCACTGGATACGACTAACCG 3′     
  mmu-miR-302c                       5′ GTCGTATCCAGTGCGTGTCGTGGAGTC
  GGCAATTGCACTGGATACGACCCACTG 3′     
  mmu-miR-295                        5′ GTCGTATCCAGTGCGTGTCGTGGAGTC
  GGCAATTGCACTGGATACGACAGACTCAA 3′   
  mmu-miR-20b                        5′ GTCGTATCCAGTGCGTGTCGTGGAGTC
  GGCAATTGCACTGGATACGACCTACCT 3′     
  U6                                 5′ CGCTTCACGAATTTGCGTGTCAT 3′

###### 

Primers for real-time RT-PCR.

  Gene name                          Primers                              Product size (bp)
  ---------------------------------- ------------------------------------ -------------------
  mmu-miR-126-5p                     F: 5′ GGGGCATTATTACTTTTGG 3′         65
  R: 5′ CAGTGCGTGTCGTGGA 3′                                               
  mmu-miR-99a                        F: 5′ GATAACCCGTAGATCCGAT 3′         65
  R: 5′ CAGTGCGTGTCGTGGA 3′                                               
  mmu-miR-324-5p                     F: 5′ CGCATCCCCTAGGGCA 3′            61
  R: 5′ GTGCGTGTCGTGGAGTCG 3′                                             
  mmu-miR-762                        F: 5′ ATGCTGGGGCCGGGA 3′             59
  R: 5′ GTGCGTGTCGTGGAGTCG 3′                                             
  mmu-miR-29a                        F: 5′ GGGTAGCACCATCTGAAAT 3′         62
  R: 5′ TGCGTGTCGTGGAGTC 3′                                               
  mmu-miR-302c                       F: 5′ GGCAAGTGCTTCCATGTTT 3′         65
  R: 5′ CAGTGCGTGTCGTGGAGT 3′                                             
  mmu-miR-295                        F: 5′ GGGGGAAAGTGCTACTACTT 3′        68
  R: 5′ CAGTGCGTGTCGTGGAG 3′                                              
  mmu-miR-20b                        F: 5′ GGACAAAGTGCTCATAGTGC 3′        66
  R: 5′ CAGTGCGTGTCGTGGAGT 3′                                             
  U6                                 F: 5′ GCTTCGGCAGCACATATACTAAAAT 3′   89
  R: 5′ CGCTTCACGAATTTGCGTGTCAT 3′                                        

###### 

Primers used for miRNA target prediction.

  Gene name                          Primers                            Product size (bp)
  ---------------------------------- ---------------------------------- -------------------
  *Wnt1*                             F: 5′ GGTTTCTACTACGTTGCTACTGG 3′   121
  R: 5′ GGAATCCGTCAACAGGTTCGT 3′                                        
  *GSK3β*                            F: 5′ TGGCAGCAAGGTAACCACAG 3′      189
  R: 5′ CGGTTCTTAAATCGCTTGTCCTG 3′                                      
  *NKX2.5*                           F: 5′ CCTGCGGCCTCTACATGA 3′        222
  R: 5′ AGGGTCTCACCAGCAGGA 3′                                           
  *GAPDH*                            F: 5′ TTCACCACCATGGAGAAGGC 3′      237
  R: 5′ GGCATGGACTGTGGTCATGA 3′                                         
